subject area of
- 5-Azacytidine upregulates melatonin MT1 receptor expression in rat C6 glioma cells: oncostatic implications Academic Article
- A phase I trial of two sequence-specific schedules of decitabine and vorinostat in patients with acute myeloid leukemia Academic Article
- Application of Octanohydroxamic Acid for Salting out Liquid–Liquid Extraction of Materials for Energy Storage in Supercapacitors Academic Article
- BCL11A represses HBG transcription in K562 cells Academic Article
- Clinically relevant concentrations of valproic acid modulate melatonin MT1 receptor, HDAC and MeCP2 mRNA expression in C6 glioma cells Academic Article
- Elimination of 4-n-Butoxyphenylacethydroxamic Acid (Bufexamac) in Man Academic Article
- Epigenetic induction of melatonin MT 1 receptors by valproate: Neurotherapeutic implications Academic Article
- Estimation of 4-Butoxyphenylacetohydroxamic Acid Utilizing the Lossen Rearrangement Academic Article
- HDAC inhibitor M344 suppresses MCF-7 breast cancer cell proliferation Academic Article
- Histone Deacetylation Is Involved in the Transcriptional Repression of hTERT in Normal Human Cells Academic Article
- Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer Academic Article
- Inhibition of Helicobacter pylori by acetohydroxamic acid Academic Article
- Inhibition of leucine aminopeptidase by amino acid hydroxamates. Academic Article
- Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid. Academic Article
- Metalloprotease domain latency protects ADAMTS13 against broad-spectrum inhibitors of metalloproteases while maintaining activity toward VWF Academic Article
- Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas Academic Article
- Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer Academic Article
- Phase I/II study of the deacetylase inhibitor panobinostat after allogeneic stem cell transplantation in patients with high-risk MDS or AML (PANOBEST trial) Academic Article
- Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group Academic Article
- Phase II trial of vorinostat in advanced melanoma Academic Article
- Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases Academic Article
- Reactivation of epigenetically silenced miR-512 and miR-373 sensitizes lung cancer cells to cisplatin and restricts tumor growth Academic Article
- Reversal of p15/INK4b hypermethylation in AML1/ETO-positive and -negative myeloid leukemia cell lines Academic Article
- Synergistic binding of ligands to angiotensin-converting enzyme. Academic Article